Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Okazaki

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD miceTaku Yoshida, Fang Jiang, Tasuku Honjo, et al.
Journal for Immunotherapy of Cancer|September 15, 2020
LAG-3: from molecular functions to clinical applicationsTakumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki, et al.
The Journal of Experimental Medicine|July 9, 2003
PD-1 inhibits antiviral immunity at the effector phase in the liverYoshiko Iwai, Seigo Terawaki, Masaya Ikegawa, et al.
Nature Immunology|November 19, 2013
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical applicationTaku Okazaki, Shunsuke Chikuma, Yoshiko Iwai, et al.
International Immunology|October 1, 2021
T-cell-intrinsic and -extrinsic regulation of PD-1 functionDaisuke Sugiura, Kenji Shimizu, Takumi Maruhashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2002
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockadeYoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka, et al.
The Journal of Biological Chemistry|February 15, 2019
Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activationTakeo K Maeda, Daisuke Sugiura, Il-Mi Okazaki, et al.
International Immunology|November 5, 2010
PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-GuérinShunsuke Sakai, Ikuo Kawamura, Taku Okazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2005
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetesJian Wang, Taku Yoshida, Fumio Nakaki, et al.
The Journal of Investigative Dermatology|February 14, 2002
DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motifNobuo Kanazawa, Taku Okazaki, Hiroyuki Nishimura, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD miceTaku Yoshida, Fang Jiang, Tasuku Honjo, et al.
Journal for Immunotherapy of Cancer|September 15, 2020
LAG-3: from molecular functions to clinical applicationsTakumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki, et al.
The Journal of Experimental Medicine|July 9, 2003
PD-1 inhibits antiviral immunity at the effector phase in the liverYoshiko Iwai, Seigo Terawaki, Masaya Ikegawa, et al.
Nature Immunology|November 19, 2013
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical applicationTaku Okazaki, Shunsuke Chikuma, Yoshiko Iwai, et al.
International Immunology|October 1, 2021
T-cell-intrinsic and -extrinsic regulation of PD-1 functionDaisuke Sugiura, Kenji Shimizu, Takumi Maruhashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2002
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockadeYoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka, et al.
The Journal of Biological Chemistry|February 15, 2019
Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activationTakeo K Maeda, Daisuke Sugiura, Il-Mi Okazaki, et al.
International Immunology|November 5, 2010
PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-GuérinShunsuke Sakai, Ikuo Kawamura, Taku Okazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2005
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetesJian Wang, Taku Yoshida, Fumio Nakaki, et al.
The Journal of Investigative Dermatology|February 14, 2002
DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motifNobuo Kanazawa, Taku Okazaki, Hiroyuki Nishimura, et al.
Pageof 6